In vivo pharmacokinetics of [14C]-etanidazole
β Scribed by Alberto Breccia; Enrico Gattavecchia; Giorgio Feroci; Adamo Fini; Luciano Busutti
- Publisher
- John Wiley and Sons
- Year
- 1994
- Tongue
- French
- Weight
- 355 KB
- Volume
- 34
- Category
- Article
- ISSN
- 0022-2135
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
Etanidazole, like other nitroaromatic radio sensitizers, displays its biological activity mostly through two molecular groups: the nitro group and the sideβchain attached to the nitrogen in the imidazole ring in position 1.
To monitor the behaviour of the two moieties in vivo, labelled Etanidazole, containing a ^14^C atom in position 2 of the sideβchain was prepared and administered to four patients at a 2 gm^β2^ dose: the concentration of Etanidazole in different fluids and tissues was followed either by titrating the NO~2~ group by polarography or determining the total radioactivity, carried by the sideβchain. Two different profiles of Etanidazole concentration were found, in blood and urine, as determined by the two methods. The concentration was found to be higher when measured as total radioactivity than when measured by polarography; this difference was greater in blood (49%) than in urine (27%). Since the two methods involve determination of different portions of the Etanidazole molecule, we hypothesized a degradation of the drug to explain these differences.
π SIMILAR VOLUMES
The pharmacokinetics of labelled DMPS (sodium-1,3 ''C-2,3-dimercaptopropane-1sulphonate) have been studied in four beagle dogs following bolus intravenous injection (65.7 pmol kg-') and oral administration (197 pmol kg-'). Following intravenous injection the main kinetic parameters were t\* = 43min,